Oxygen and Aerosol Delivery Equipment Market Size Limit:

InsightAce Analytics Sp. Ltd. announces the publication of a market assessment report on “Global Oxygen and Aerosol Delivery Devices Market – By Product (Oxygen Masks, Nasal Cannulas/Oxygen Catheters, Oxygen Connecting Tube, Venturi Masks, Non-Rebreather Masks, Reusable Nebulizer, Disposable Nebulizer ) and other oxygen delivery devices), applications (COPD, asthma, cystic fibrosis, respiratory distress syndrome, pneumonia and other diseases), trends, industry competition analysis, revenues and forecast for 2031.”

Request for sample pages: https://www.insightaceanalytic.com/request-sample/1275

According to the latest research by InsightAce Analytic, the global oxygen and aerosol delivery devices market is valued at USD 43.14 billion in 2023 and is expected to reach USD 74.64 billion by 2031, at a CAGR of 7.3% over the period forecasts for 2024-2031.

Oxygen and aerosol delivery systems are used to treat respiratory and non-respiratory disorders as acute therapy or as part of a long-term treatment regimen. The most advanced method of drug administration involves injecting the substance directly into the lungs to achieve a systemic effect. Oxygen and aerosol delivery devices such as dry powder inhalers, metered dose inhalers, and nebulizers are often used to treat asthma and COPD. In addition to treating respiratory diseases, these devices are also used to treat pain, Parkinson’s disease and diabetes. Asthma, COPD and other respiratory diseases are becoming more common, smoking is becoming more popular, the demand for metered dose inhalers is increasing and it is becoming easier to prescribe medications using aerosol delivery systems.

Increased incidence of respiratory diseases such as asthma, COPD and others, prevalence of smoking, ease of administering drugs through aerosol delivery devices, increase in demand for metered dose inhalers and technological advancements in inhalers are the major underlying factors influencing the global devices market for oxygen and aerosol delivery. The number of research and development initiatives aimed at providing the best inhalation therapy has increased, which is one of the other factors influencing the market expansion. However, problems and adverse effects related to inhalation of drugs and high price of nebulizers are expected to hamper the market growth.

North America is expected to account for the largest share of the oxygen and aerosol delivery devices market during the forecast years. Due to the significant population base susceptible to asthma and COPD, increasing health care reforms, increasing public awareness of the use and benefits of these devices, the availability of medical devices, the growth of the research and development sector and technological advances in aerosol delivery devices, the oxygen and device sector for aerosol delivery offers lucrative opportunities for key players. Moreover, the Asia-Pacific oxygen and aerosol delivery devices market is expected to grow significantly during the forecast period. The market is showing significant growth due to the increasing demand for home health care equipment, inhalers and nebulizers. To capture a significant share of the oxygen and aerosol supply business, prominent manufacturers are increasingly focusing on expanding their geographic presence in developing countries in Asia-Pacific.

Order this premium report: https://www.insightaceanalytic.com/buy-report/1275

Major market players operating in the oxygen and aerosol delivery devices market include:
Medline Industries, Inc., Salter Labs Inc., Vygon SA, Smiths Medical, Inc., Medicoplast International GmbH, Purple Surgical, Pennine Healthcare, Besmed Health Business Corp., Intersurgical Ltd, B. Braun Melsungen AG, ConvaTec Inc., Flexicare Medical Ltd., GaleMed Corporation, PARI GmbH, Polymedicure, Teleflex Incorporated, HSINER CO., LTD., ASID BONZ GmbH and Sumi limited liability company.

Recent collaborations and agreements on the market:
• In December 2021, Pulmotect reported positive results from a second randomized, placebo-controlled Phase 2 trial comparing PUL-042 with COVID-19. Patients treated with inhaled PUL-042 had excellent efficacy signals for COVID-19 prevention and therapy, with improved respiratory symptoms and reduced intensive care unit hospitalizations, as well as probable efficacy against all SARS-CoV-2 variants.
• In June 2021, a significant portion of Teleflex Incorporated’s Respiratory business was recently sold to Medline Industries, Inc. (hereinafter “Medline”) as previously stated. Teleflex’s respiratory product lines acquired include Hudson RCI® devices for oxygen and aerosol therapy, active humidification, non-invasive ventilation and incentive spirometers, with expected total 2020 sales of $139 million.

Are you curious about the latest version of the report? Get report details @ https://www.insightaceanalytic.com/enquiry-before-buying/1275

Market segments
Global Oxygen and Aerosol Delivery Devices Market by Product, 2024-2031 ($Mn Value)
• Oxygen masks
• Nasal cannulas/oxygen catheter
• Oxygen connecting tube
• Venturi masks
• Non-rebreather masks
• Reusable nebulizer
• Disposable nebulizer
• Other oxygen supply devices

Global Oxygen and Aerosol Delivery Devices Market by Application, 2024-2031 ($Mn Value)
• COPD
• Asthma
• Cystic fibrosis
• Respiratory distress syndrome
• Pneumonia
• Other diseases

Global Oxygen and Aerosol Delivery Devices Market by Region, 2024-2031 ($Mn Value)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

North America Oxygen and Aerosol Delivery Devices Market, by Country, 2024-2031 (USD Million Value)
• US
• Canada

European Oxygen and Aerosol Delivery Devices Market by Country, 2024-2031 (USD Million Value)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia-Pacific Oxygen and Aerosol Delivery Devices Market, by Country, 2024-2031 ($Mn Value)
• India
• China
• Japan
• South Korea
• Australia and New Zealand

Latin America Oxygen and Aerosol Delivery Devices Market by Country, 2024-2031 ($Mn Value)
• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa Oxygen and Aerosol Delivery Devices Market, by Country, 2024-2031 ($Mn Value)
• GCC countries
• South Africa
• Rest of the Middle East and Africa

Why you should buy this report:
 To obtain a comprehensive analysis of the prospects of the global Oxygen and Aerosol Delivery Devices market
 To get an overview of the industry and future trends in the Oxygen and Aerosol Delivery Devices market
 To analyze the factors influencing the Oxygen and Aerosol Delivery Devices market and the challenges
 Obtaining information on the projected market value of oxygen and aerosol delivery devices (in USD million) by 2030
 Significant investments, mergers and acquisitions in the oxygen and aerosol delivery devices market industry

For more information @ https://www.insightaceanalytic.com/customisation/1275

[email protected]
InsightAce Analytics Sp. Sp. z o. o
Visit: www.insightaceanalytic.com
Tel: +1 551 226 6109
Asia: +91 79 72967118
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/InsightaceA

InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to grow businesses. We help clients gain competitive advantage by identifying untapped markets, discovering new and competitive technologies, segmenting potential markets and repositioning products. Our specialty is delivering syndicated and custom market intelligence reports with in-depth analysis containing key market insights in a timely and cost-effective manner.

This release was published on openPR.